Critical evaluation of a decision-analytic model of major depression treatment

Research output: Contribution to journalArticle

Abstract

Antidepressants are typically one of the most costly drug classes in the drug budget. Due to the higher costs of many of the newer antidepressants, a number of studies have been conducted to evaluate the clinical and cost aspects of depression treatment. The purpose of this month's Practical Pharmacoeconomics column is to assist readers in interpreting a cost- effectiveness evaluation of antidepressant drugs that used a decision tree model to assess the treatment of major depression.

Original languageEnglish (US)
Pages (from-to)683-687
Number of pages5
JournalFormulary
Volume34
Issue number8
StatePublished - Aug 1999

Fingerprint

Antidepressive Agents
Costs and Cost Analysis
Pharmaceutical Economics
Decision Trees
Budgets
Pharmaceutical Preparations
Cost-Benefit Analysis

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Critical evaluation of a decision-analytic model of major depression treatment. / Armstrong, Edward P.

In: Formulary, Vol. 34, No. 8, 08.1999, p. 683-687.

Research output: Contribution to journalArticle

@article{b4e4317c7b914f9f96466766a9d04e42,
title = "Critical evaluation of a decision-analytic model of major depression treatment",
abstract = "Antidepressants are typically one of the most costly drug classes in the drug budget. Due to the higher costs of many of the newer antidepressants, a number of studies have been conducted to evaluate the clinical and cost aspects of depression treatment. The purpose of this month's Practical Pharmacoeconomics column is to assist readers in interpreting a cost- effectiveness evaluation of antidepressant drugs that used a decision tree model to assess the treatment of major depression.",
author = "Armstrong, {Edward P}",
year = "1999",
month = "8",
language = "English (US)",
volume = "34",
pages = "683--687",
journal = "Formulary",
issn = "1082-801X",
publisher = "Advanstar Communications",
number = "8",

}

TY - JOUR

T1 - Critical evaluation of a decision-analytic model of major depression treatment

AU - Armstrong, Edward P

PY - 1999/8

Y1 - 1999/8

N2 - Antidepressants are typically one of the most costly drug classes in the drug budget. Due to the higher costs of many of the newer antidepressants, a number of studies have been conducted to evaluate the clinical and cost aspects of depression treatment. The purpose of this month's Practical Pharmacoeconomics column is to assist readers in interpreting a cost- effectiveness evaluation of antidepressant drugs that used a decision tree model to assess the treatment of major depression.

AB - Antidepressants are typically one of the most costly drug classes in the drug budget. Due to the higher costs of many of the newer antidepressants, a number of studies have been conducted to evaluate the clinical and cost aspects of depression treatment. The purpose of this month's Practical Pharmacoeconomics column is to assist readers in interpreting a cost- effectiveness evaluation of antidepressant drugs that used a decision tree model to assess the treatment of major depression.

UR - http://www.scopus.com/inward/record.url?scp=0032784258&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032784258&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0032784258

VL - 34

SP - 683

EP - 687

JO - Formulary

JF - Formulary

SN - 1082-801X

IS - 8

ER -